Page last updated: 2024-08-21

alpha-aminopyridine and Impotence

alpha-aminopyridine has been researched along with Impotence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, C; Li, Y; Wang, B; Wen, J; Xu, G; Zhang, N; Zhang, Z1
Attkins, N; Betts, A; Heatherington, AC; Hepworth, D1

Trials

1 trial(s) available for alpha-aminopyridine and Impotence

ArticleYear
Pharmacokinetics and elucidation of the rates and routes of N-glucuronidation of PF-592379, an oral dopamine 3 agonist in rat, dog, and human.
    Xenobiotica; the fate of foreign compounds in biological systems, 2010, Volume: 40, Issue:11

    Topics: Administration, Oral; Aminopyridines; Animals; Biometry; Blood Proteins; Caco-2 Cells; Dogs; Dopamine Agonists; Drug Evaluation, Preclinical; Erectile Dysfunction; Female; Glucuronosyltransferase; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microsomes, Liver; Morpholines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3

2010

Other Studies

1 other study(ies) available for alpha-aminopyridine and Impotence

ArticleYear
A2B Adenosine Receptor Agonist Improves Erectile Function in Diabetic Rats.
    The Tohoku journal of experimental medicine, 2015, Volume: 237, Issue:2

    Topics: Adenosine A2 Receptor Agonists; Aminopyridines; Animals; Cyclic AMP; Diabetes Mellitus, Experimental; Electric Stimulation; Erectile Dysfunction; Male; Muscle, Smooth; Neurons; Penile Erection; Penis; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; RNA, Messenger

2015